UAB "Pharmasanta group" Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 75,150 |
| 19,025 |
| 1,440,679 |
| 1,440,679 |
| 364,729 |
| 14.23 |
| 1,917.07 |
| -6,432 |
| 11,264,332 |
| 10,918,240 |
| 339,603 |
| 2024 |
|---|
| 57,600 |
| 25,374 |
| 1,754,546 |
| 1,754,546 |
| 772,928 |
| 30.60 |
| 3,046.09 |
| 1,748,115 |
| 11,709,581 |
| 13,396,779 |
| 60,428 |
| 2025 |
|---|
| 12,600 |
| 6,300 |
| 594,337 |
| -594,337 |
| -297,169 |
| -202.35 |
| -4,716.96 |
| 1,443,778 |
| 12,115,614 |
| 13,392,758 |
| 166,598 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 12,600 |
| 6,300 |
| 594,337 |
| -594,337 |
| -297,169 |
| -202.35 |
| -4,716.96 |
| 1,443,778 |
| 12,115,614 |
| 13,392,758 |
| 166,598 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
12,600 €-78 % *
Sales per employee (€)
6,300 €-75 % *
Profit before tax (€)
594,337 €-66 % *
Net Profit (€)
-594,337 €-134 % *
Profit per employee (€)
-297,169 €-138 % *
Total profitability (%)
-202.35 %-761.27 % *
Net profitability (%)
-4,716.96 %-254.85 % *
Equity (€)
1,443,778 €-17 % *
Amounts Payable And Liabilities (€)
12,115,614 €3 % *
Non-current Assets (€)
13,392,758 €0 % *
CurrentAssets (€)
166,598 €176 % *
